The aim of this study is to evaluate the brainstem function in DYT1 carriers manifesting clinical dystonia (MDYT1) and those without clinical symptoms (NMDYT1). Motor cortical inhibition and plasticity were found to be abnormal in MDYT1, whereas these were less abnormal in NMDYT1. However, the spinal reciprocal inhibition was abnormal in MDYT1, but normal in NMDYT1. Moreover, protein accumulation and perinuclear inclusion bodies were found in the brainstem, but not in other brain areas, in DYT1 patients. Therefore, we designed this study to investigate the brainstem physiology using the blink reflex (BR) recovery cycle test in MDYT1 and NMDYT1. We recruited eight MDYT1, five NMDYT1, and nine age-matched healthy controls. The BR recovery cycle was assessed with paired stimuli that induced the BR in a random order at interstimulus intervals of 250, 500, and 1000 ms. A two-way analysis of variance showed a significant difference between MDYT1, NMDYT1, and the healthy control (P = 0.004). Post-hoc analysis showed that this was because of a significantly lower inhibition of R2 in MDYT1 and NMDYT1 compared with the controls (two-way analysis of variance: P = 0.003 and 0.021, respectively). There was no difference between MDYT1 and NMDYT1 (P = 0.224). The tested brainstem circuits were equally involved in MDYT1 and NMDYT1. The finding is in agreement with the pathological findings in DYT1 carriers. Together with previous findings in the motor cortex and the spinal cord, the brainstem may lie closer to the pathogenesis of dystonia than the motor cortex in DYT1 gene carriers.
Introduction
Dystonia is a kind of hyperkinetic movement disorder with clinical features of abnormal sustained limbs or a trunk twisting posture. The neurophysiology studies have shown dysfunction in the basal ganglion-sensorimotor network [1, 2] , dysfunction in the cerebellothalamocortical pathway [3] , reduced cortical inhibition with increased cortical plasticity [4] , abnormal premotor-motor connectivity [5, 6] and decreased brainstem inhibition [1, 2, 7, 8] , and reduced spinal cord reciprocal inhibition [9, 10] . Recent findings suggested that dystonia could be a brain network disorder, and the basal ganglion may not be the primary source of development of the entire dysfunction network of dystonia [11] . Hence, the exact pathogenesis of dystonia has remained unclear so far.
In primary dystonia, DYT1-related dystonia is the most common cause of early-onset primary general dystonia [12] . DYT1 dystonia is a familial early-onset dystonia because of a single GAG deletion in the DYT1 gene and produces the abnormal TorsinA protein with a single glutamate residue deletion in the C-terminus [13] . Although DYT1-related dystonia is an autosomal dominant disorder, only 30-40% of gene carriers eventually develop dystonia. The others may not manifest any limbs or truncal twisting symptoms [7] . Hence, it would be useful to understand the pathogenesis of dystonia by clarifying the pathophysiology of DYT1 gene mutation carriers with clinical manifesting dystonia (MDYT1) and without dystonia (NMDYT1). A previous study discovered that motor cortical inhibition was reduced in both MDTY1 and NMDYT1 patients, although the reduction in short-interval intracortical inhibition (SICI) was minor in NMDYT1 than in MDYT1 patients [14] . In addition, motor plasticity in response to theta burst stimulation from of rTMS was enhanced in MDYT1, but reduced in NMDYT1 patients [4] . In contrast, the spinal reciprocal inhibition was reduced in MDYT1, but normal in NMDYT1 [14] . The results indicate that motor cortical plasticity and inhibitory circuits are abnormal in both MDYT1 and NMDYT1 patients, whereas the spinal cord inhibition is abnormal only in MDYT1.
A pathology study of MDYT1 showed that protein accumulation and perinuclear inclusion bodies presented only in the brainstem, not the basal ganglion or the cortex [15] . In addition, a recent study of the eye blink physiology also showed an enhanced blink reflex (BR) recovery curve in DYT1 dystonia patients [8] . The BR recovery cycle, which is studied by paired stimuli over the supraorbital nerve at a variety of interstimulus intervals, has commonly been used to assess the brainstem excitatory and inhibitory circuits within the brainstem. Enhanced BR recovery has been reported in patients with movement disorders, for example, parkinsonism and dystonia [8, [16] [17] [18] . However, the brainstem physiology has never been studied in nonmanifesting DYT1 patients. Therefore, it would be useful to compare and contrast the brainstem physiology of MDYT1 and NMDYT1. For this purpose, we carried out this study to evaluate the BR recovery cycle in MDYT1 and NMDYT1.
Methods

Participants
We recruited eight DYT1 gene carriers (four men and four women, average age 46 13.76 years) manifesting dystonia symptoms (MDYT1) and five carriers (four men and one woman, average age 43.6 15.43 years) without manifesting dystonia symptoms (NMDYT1) from the movement disorder clinics at the National Hospital for Neurology and Neurosurgery in London, UK, and at the Chang Gung Memorial Hospital at Linkou, Taiwan. None of the DYT1 carriers showed lesions in their MRI. Nine age-matched healthy individuals (six men and three women, average age 46 7.05 years) were recruited as healthy controls. They provided informed consent before participation. The experiments were conducted with the approval of the Institutional Review Board of the Chang Gung Memorial Hospital, Taiwan, and the National Hospital for Neurology and Neurosurgery in London, UK.
Blink reflex recovery cycle
Surface electromyography recording Ag-AgCl electrodes at about 1-cm-diameter were placed bilaterally, with the active electrode at the orbicularis oculi muscle just below the lateral canthi and the reference electrode at the temporal region. Electric stimuli were administered by a constant current generator (DS7A; Digitimer, Welwyn, UK) with electrodes attached over the right supraorbital nerve. Stimulation was provided at an intensity 2.5 times the sensory threshold, an intensity that was capable of producing a clear R1 and R2 component when a single stimulus was administered. BR was tested on the right eye. Pairs of (conditioning, followed by test) stimuli were provided every 13.5∼16.5 seconds at interstimulus intervals (ISIs) of 250, 500, and 1000 ms in a random order for 12 trials per condition.
Data analysis
We measured the BR recovery curve by calculating the R2 area ratio (the area of R2 evoked by test stimulation divided by the area of R2 evoked by conditioning stimulation) at each trial. The R2 area ratio was then averaged at each ISI. A two-way analysis of variance (ANOVA) was carried out to compare the R2 area ratio at the three tested ISI (250, 500, and 100 ms) between all three participant groups (MDYT1, NMDYT1, and controls). The following two-way ANOVAs were carried out to compare each pair of participant groups. SPSS 22.0 (SPSS for windows, IBM, Armonk, New York, USA) was used for statistical analysis. We set the threshold of statistical significance at P less than 0.05.
Result
A two-way ANOVA showed a significant difference between the three groups (MDYT1, NMDYT1, and controls) [F(2,19) = 7.53, P = 0.004] (Fig. 1 ). Further two-way ANOVA analysis confirmed that this was because of significant enhancement of the recovery of the R2 component of the BR in MDYT1 and NMDYT1 compared with the controls [F(1,15) = 12.05, P = 0.003, F(1,12) = 6.998, P = 0.021, respectively]. There was no difference between MDYT1 and NMDYT1 [F(1,11) = 1.663, P = 0.224], indicating that MDYT1 and NMDYT1 carriers have equivalent disinhibitions in the BR pathway in the brainstem.
Discussion
In our data, both MDYT1 and NMDYT1 showed an abnormally enhanced BR recovery curve compared with the healthy controls. Moreover, the lack of a statistical difference between manifesting and nonmanifesting carriers suggests that their brainstem circuits are equivalently affected by the DYT1 gene.
Abnormal BR recovery curve suggests disinhibition of the interneuronal pathway mediating the R2 component in BR. A similar abnormality has commonly been reported in different forms of primary dystonia [7] . The central pathway of R2 response in the BR is multisynaptic and involves several nuclei and tracts, including spinal 
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The blink reflex recovery curve in MDYT1, NMDYT1, and normal controls. Both MDYT1 and NMDYT1 groups showed significant enhancement at the blink reflex recovery than the normal control group, whereas there was no difference between MDYT1 and NMDYT1 groups. * = P<0.05.
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trigeminal nucleus and laterobubal reticular formation, in the pons [19] . The current result suggests that the R2 BR pathway or the structures closely interact with it, e.g. the pedunculopontine nucleus (PPN) [20] , may be involved in the pathogenesis of dystonia in DYT1 carriers.
Enhanced BR recovery is commonly observed in focal or generalized dystonia, including dystonic tremor [21] , or benign essential blepharospasm [18] , but not DYT6, and has been reported in other movement disorders, for example, Parkinson's disease and progressive supranuclear palsy [22] . In addition, other neurological disorders, for example, multiple sclerosis, causing brainstem lesions may present similar enhanced BR recovery [23] . Therefore, enhanced BR recovery is not specific to dystonia or DYT1, but indicates abnormal central inhibition within the brainstem.
Previous studies have reported that both MDYT1 and NMDYT1 are abnormal in the motor cortex. However, the abnormality pattern is different between manifesting and nonmanifesting carriers. Although SICI and cortical silent period were reduced in both MDYT1 and NMDYT1 compared with the healthy controls, SICI in MDYT1 was significantly less than that in NMDYT1 [14] . The two types of DYT1 carriers also responded differently to continuous theta burst stimulation and showed considerable plasticity in MDYT1 and reduced plasticity in NMDYT1 [4] . Interestingly, at the spinal level, the second and third phases of reciprocal inhibition were reduced in manifesting carriers, whereas the reciprocal inhibition was normal in nonmanifesting patients [14] . Together with the above results, the equal abnormality in the brainstem reflex in MDYT1 and NMDYT1 implies that the brainstem may therefore lie closer to the primary mechanism of DYT1 dystonia than the motor cortex.
Our finding is further supported by a pathological study of clinically manifesting DYT1 patients showing protein accumulation and inclusion bodies in cells located in the brainstem, but not in the cortex, cerebellum, or basal ganglion or substantial nigra [15] . The perinuclear inclusion bodies mainly exist in the midbrain, periaqueductal gray, and pontine reticular formation, and are also observed in the rostral pons such as the PPN, the cuneiform nucleus, and the griseum centrale mesencephali, which are related to muscle tone control and mediate motor activities [15] .
Functional neuroimaging studies indicated the ascending influence in the cerebellothalamocortical pathway in DYT1 gene carriers and mice models [3, 24] . Some of the pathologically involved structures, for example, PPN, received the input information from cerebellum output flow and transport to basal ganglion by the ascending pathway [25] . Furthermore, a study of eye blinking in dystonic patients with a gene mutation in DYT1 discovered similar enhanced blinking reflex recovery, but normal cerebellar function [8] . Therefore, it is reasonable to speculate that the brainstem dysfunction affects the ascending pathway to cause dystonia in DYT1 carriers. However, we cannot completely rule out the possibility that the brainstem disinhibition here was caused by the dysfunction of the cerebellum.
Conclusion
In line with previous pathological findings, the present study found disinhibition in the brainstem of DYT1 carriers. Together with previous physiological and pathological results, the equal amount of dysfunction in clinically manifesting and nonmanifesting carrier implies that the brainstem is likely at a level above the motor cortex and, probably, the cerebellum and lies very close to the pathogenesis of dystonia in DYT1 gene carriers.
